Genetic background of multiple sclerosis

Autoimmunity Reviews

Volumn 11, Issue 3, 2012, Pages 163-166

  Sadovnick, A Dessa ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Common complex diseases; Epstein Barr virus; HLA; Multiple sclerosis; Vitamin D

Indexed keywords

HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; HLA DRB5 ANTIGEN; VITAMIN D;

DISEASE PREDISPOSITION; GENE INTERACTION; GENE LOCUS; GENETIC BACKGROUND; GENETIC PARAMETERS; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; NONHUMAN; REVIEW;

CANADA; EPISTASIS, GENETIC; EPSTEIN-BARR VIRUS INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HERPESVIRUS 4, HUMAN; HLA-DRB1 CHAINS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIFACTORIAL INHERITANCE; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; RISK; SEX FACTORS; VITAMIN D;

EID: 84855959306     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.05.007     Document Type: Review

References (34)

1. (retrieved October 12, 2010). http://www.medterms.com/script/main/art.asp?articlekey=13052.
2. (retrieved October 12, 2010). http://www.nchpeg.org/index.php?option=com_content&view=article&id=96&Itemid=82.
3. Ebers G.C. Enviromental factors and multiple sclerosis. Lancet Neurol 2008, 7:268-277.
4. Ramagopalan R.V., Dyment D.A., Ebers G.C. Genetic epidemiology: the use of old and new tools for multiple sclerosis. Trends Neurosci 2008, 31:645-652.
5. Ramagopalan R.V., Ebers G.C. Epistasis: multiple sclerosis and the major histocompatibility complex. Neurology 2009, 72:566-567.
6. Fogdell A., Hillert J., Sachs C., Olerup O. The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens 1995, 46:333-336.
7. Dyment D.A., Ebers G.C., Sadovnick A.D. Genetics of multiple sclerosis. Lancet Neurol 2004, 3:104-110.
8. Lassmann H. Neuropathology in multiple sclerosis: new concepts. Mult Scler 1998, 4:93-98.
9. Orton S.M., Herrrera B.M., Yee I.M., Valdar W., Ramagopalan S.V., Sadovnick A.D., et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006, 5:932-936.
10. Vukusic S., Hutchinson M., Hours M., Moreau T., Cortinovis-Tourniaire P., Adeleine P., et al. The Pregnancy In Multiple Sclerosis Group; Pregnancy In Multiple Sclerosis Group. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004, 127:1353-1360.
11. Olsson T., Zhi W.W., Höjeberg B., Kostulas V., Jiang Y.P., Anderson G., et al. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. J Clin Invest 1990, 86:981-985.
12. Dyment D.A., Herrera B.M., Cader M.Z., Willer C.J., Lincoln M.R., Sadovnick A.D., et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 2005, 14:2019-2026.
13. Chao M.J., Barnardo M.C., Lincoln M.R., Ramagopalan S.V., Herrera B.M., Dyment D.A., et al. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci U S A 2008, 105:13069-13074.
14. Chao M.J., Ramagopalan S.V., Herrera B.M., Lincoln M.R., Dyment D.A., Sadovnick A.D., et al. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. Hum Mol Genet 2009, 18:261-266.
15. Ramagopalan S.V., McMahon R., Dyment D.A., Sadovnick A.D., Ebers G.C., Wittkowski K.M. An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1 gene. BMC Med Genet 2009 Feb 4, 10:10.
16. Bias W.B., Reveille J.D., Beaty T.H., Meyers D.A., Arnett F.C. Evidence that autoimmunity in man is a Mendelian dominant trait. Am J Hum Genet 1986, 39:584-602.
17. Becker K.G., Simon R.M., Bailey-Wilson J.E., Freidlin B., Biddison W.E., McFarland H.F., et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci U S A 1998, 95:9979-9984.
18. Heinzlef O., Alamowitch S., Sazdovitch V., Chillet P., Joutel A., Tournier-Lasserve E., et al. Autoimmune diseases in families of French patients with multiple sclerosis. Acta Neurol Scand 2000, 101:36-40.
19. Barcellos L.F., Kamdar B.B., Ramsay P.P., DeLoa C., Lincoln R.R., Caillier S., et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol 2006, 5:924-931.
20. Baranzini S.E. The genetics of autoimmune diseases: a networked prospective. Curr Opin Immunol 2009, 21:596-605.
21. Henderson R.D., Bain C.J., Pender M.P. The occurrence of autoimmune diseases in patients with multiple sclerosis and their families. J Clin Neurosci 2000, 7:434-437.
22. Ramagopalan S.V., Dyment D.A., Herrera B.M., Criscuoli M., Yee I.M., Sadovnick A.D., et al. Clustering of autoimmune disease in families at high risk for multiple sclerosis?. Lancet Neurol 2007, 6:206-207.
23. Ramagopalan S.V., Valdar W., Dyment D.A., DeLuca G.C., Yee I.M., Giovannoni G., et al. Asssociation of infectious mononucleosis with multiple sclerosis: a population-based study. Neuroepidemiology 2009, 32:257-262.
24. Masterman T., Ligers A., Olsson T., Andersson M., Olerup O., Hillert J. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 2000, 48:211-219.
25. Modin H., Olsson W., Hillert J., Masterman T. Modes of action of HLA-DR susceptibility specificities in multiple sclerosis. Am J Hum Genet 2004, 74:1321-1322.
26. Ramagopalan S.V., Morris A.P., Dyment D.A., Herrera B.M., Deluca G.C., Lincoln M.R., et al. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet 2007 Sep, 3(9):1607-1613.
27. Handel A.E., Ebers G.C., Ramagopalan S.V. Epigenetics: molecular mechanisms and implications for disease. Trends Mol Med 2010, 16:7-16.
28. Erlich H., Valdes A.M., Noble J., Carlson J.A., Varney M., Concannon P., et al. Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008, 57:1084-1092.
29. Brynedal B., Duvefelt K., Jonasdottir G., Roos I.M., Akesson E., Palmgren J., et al. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS One 2007 Jul 25, 2(7):e664.
30. Lincoln M.R., Montpetit A., Cader M.Z., Saarela J., Dyment D.A., Tiislar M., et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005, 37:1108-1112.
31. Lang H.L., Jacobsen H., Ikemizu S., Andersson C., Harlos K., Madsen L., et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002, 3:940-943.
32. Casiraghi C., Dorovini-Zis K., Horwitz M. Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis. J Neuroimmunol Sep 6 2010, 10.1016/jneuroim.2010.08.003.
33. Ramagopalan S.V., Maugeri N.J., Handunnetthi L., Lincoln M.R., Orton S.M., Dyment D.A., et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009 Feb, 5(2):e1000369.
34. Handunnetthi L., Ramagopalan S.V., Ebers G.C. Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology 2010, 74:1905-1910.